This study provides solutions to the pressing need to identify factors that influence Alzheimer’s disease risk or resistance while offering a means explore potential biological markers and therapeutic targets.
Read More
When it comes to Alzheimer’s disease, what we say – and how we say it – matters more than we might think. A new article
Read More
The findings suggest a strategy to lower tau levels and explore the potential effects in Alzheimer’s disease and tau-induced dementias.
Read More
This study opens the door to potential new strategies to slow, reverse and treat neurodegenerative conditions.
Read More
The findings not only provide new insight into the factors regulating healthy memory but also in conditions associated with memory loss, like Alzheimer’s disease.
Read More
This work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease.
Read More
The recent approval of Leqembi (lecanemab-irmb) by the U.S. Food and Drug Administration as a treatment for Alzheimer’s disease (AD) marks the first amyloid beta-directed
Read More
This approach, called Evolutionary Action Machine Learning, enables researchers to probe smaller cohorts with greater accuracy.
Read More
This post is a preview of a presentation for the Baruch A. Brody Lecture in Bioethics. Want to learn more about this topic? Tune into the lecture Feb.
Read More
This study highlights the importance of brain inflammation and other complex events involved in the development of Alzheimer’s disease.
Read More